| 1 |
32974447 | Acute thrombosis of everolimus-eluting platinum chromium stent caused by impaired prasugrel metabolism due to cytochrome P450 enzyme 2B6*2 (C64T) polymorphism: a case report. | 2020 Aug |
1 |
| 2 |
30993551 | Inhibitory Effect of Vonoprazan on the Metabolism of [14C]Prasugrel in Human Liver Microsomes. | 2019 Oct |
1 |
| 3 |
24245489 | First report of a subacute stent thrombosis in a prasugrel resistant patient successfully managed with ticagrelor. | 2014 |
1 |
| 4 |
23615745 | Cytochrome P450 2B6 and 2C9 genotype polymorphism--a possible cause of prasugrel low responsiveness. | 2013 Jul |
2 |
| 5 |
28520385 | Prasugrel Therapy and CYP Genotype | 2012 |
1 |
| 6 |
21550074 | Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients. | 2011 Nov |
3 |
| 7 |
21053990 | Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel. | 2010 Dec |
1 |
| 8 |
19047469 | Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel. | 2009 Mar |
3 |
| 9 |
19530977 | Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects. | 2009 Aug |
1 |
| 10 |
18094219 | Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans. | 2008 Jan |
4 |
| 11 |
19122335 | Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. | 2008 |
1 |